DECIBEL CANNABIS CO INC (DB.CA) Fundamental Analysis & Valuation

TSX-V:DB • CA2434371001

Current stock price

0.125 CAD
0 (0%)
Last:

This DB.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. DB.CA Profitability Analysis

1.1 Basic Checks

  • DB had negative earnings in the past year.
  • In the past year DB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: DB reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: DB reported negative operating cash flow in multiple years.
DB.CA Yearly Net Income VS EBIT VS OCF VS FCFDB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

  • The Return On Assets of DB (7.97%) is better than 87.88% of its industry peers.
  • DB has a better Return On Equity (18.35%) than 90.91% of its industry peers.
Industry RankSector Rank
ROA 7.97%
ROE 18.35%
ROIC N/A
ROA(3y)0.61%
ROA(5y)-1.43%
ROE(3y)0.45%
ROE(5y)-4.55%
ROIC(3y)N/A
ROIC(5y)N/A
DB.CA Yearly ROA, ROE, ROICDB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

1.3 Margins

  • DB's Profit Margin of 10.67% is amongst the best of the industry. DB outperforms 84.85% of its industry peers.
  • In the last couple of years the Profit Margin of DB has grown nicely.
  • The Gross Margin of DB (21.98%) is worse than 69.70% of its industry peers.
  • In the last couple of years the Gross Margin of DB has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 10.67%
GM 21.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.46%
PM growth 5YN/A
GM growth 3Y72.19%
GM growth 5Y-2.05%
DB.CA Yearly Profit, Operating, Gross MarginsDB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DB.CA Health Analysis

2.1 Basic Checks

  • DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DB has been increased compared to 1 year ago.
  • The number of shares outstanding for DB has been increased compared to 5 years ago.
  • DB has a better debt/assets ratio than last year.
DB.CA Yearly Shares OutstandingDB.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
DB.CA Yearly Total Debt VS Total AssetsDB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 1.04, we must say that DB is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.04, DB is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • DB has a debt to FCF ratio of 18.67. This is a negative value and a sign of low solvency as DB would need 18.67 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 18.67, DB is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • A Debt/Equity ratio of 0.54 indicates that DB is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.54, DB is doing worse than 60.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 18.67
Altman-Z 1.04
ROIC/WACCN/A
WACC7.96%
DB.CA Yearly LT Debt VS Equity VS FCFDB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.34 indicates that DB should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.34, DB is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.61 indicates that DB may have some problems paying its short term obligations.
  • DB has a worse Quick ratio (0.61) than 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 0.61
DB.CA Yearly Current Assets VS Current LiabilitesDB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. DB.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 816.22% over the past year.
  • The Earnings Per Share has been growing by 90.70% on average over the past years. This is a very strong growth
  • DB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.11%.
  • Measured over the past years, DB shows a very strong growth in Revenue. The Revenue has been growing by 71.51% on average per year.
EPS 1Y (TTM)816.22%
EPS 3Y90.7%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y20.83%
Revenue growth 5Y71.51%
Sales Q2Q%36.51%

3.2 Future

  • The Earnings Per Share is expected to grow by 71.68% on average over the next years. This is a very strong growth
  • DB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.33% yearly.
EPS Next Y100%
EPS Next 2Y101%
EPS Next 3Y71.68%
EPS Next 5YN/A
Revenue Next Year23.69%
Revenue Next 2Y20.05%
Revenue Next 3Y15.54%
Revenue Next 5Y10.33%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DB.CA Yearly Revenue VS EstimatesDB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M
DB.CA Yearly EPS VS EstimatesDB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2021 2022 2023 2024 2026 2027 0 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

5

4. DB.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • DB is valuated cheaply with a Price/Forward Earnings ratio of 6.13.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DB indicates a rather cheap valuation: DB is cheaper than 90.91% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. DB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 6.13
DB.CA Price Earnings VS Forward Price EarningsDB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, DB is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 29.43
EV/EBITDA N/A
DB.CA Per share dataDB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1 0.15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DB's earnings are expected to grow with 71.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y101%
EPS Next 3Y71.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DB.CA Dividend Analysis

5.1 Amount

  • No dividends for DB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DB.CA Fundamentals: All Metrics, Ratios and Statistics

DECIBEL CANNABIS CO INC

TSX-V:DB (3/26/2026, 7:00:00 PM)

0.125

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-19
Earnings (Next)04-20
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.83%
Ins Owner ChangeN/A
Market Cap72.13M
Revenue(TTM)109.31M
Net Income(TTM)11.66M
Analysts80
Price Target0.27 (116%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.87%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)7.97%
Revenue beat(4)1
Avg Revenue beat(4)-3.1%
Min Revenue beat(4)-13.84%
Max Revenue beat(4)7.97%
Revenue beat(8)2
Avg Revenue beat(8)-5.36%
Revenue beat(12)5
Avg Revenue beat(12)1.08%
Revenue beat(16)5
Avg Revenue beat(16)-1.07%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)N/A
EPS NY rev (3m)-100%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)-4.08%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.13
P/S 0.66
P/FCF 29.43
P/OCF 18.23
P/B 1.13
P/tB 1.15
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0.02
Fwd EY16.32%
FCF(TTM)0
FCFY3.4%
OCF(TTM)0.01
OCFY5.48%
SpS0.19
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.97%
ROE 18.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.67%
GM 21.98%
FCFM 2.24%
ROA(3y)0.61%
ROA(5y)-1.43%
ROE(3y)0.45%
ROE(5y)-4.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.46%
PM growth 5YN/A
GM growth 3Y72.19%
GM growth 5Y-2.05%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 18.67
Debt/EBITDA N/A
Cap/Depr 23.63%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 21.01%
Current Ratio 1.34
Quick Ratio 0.61
Altman-Z 1.04
F-Score6
WACC7.96%
ROIC/WACCN/A
Cap/Depr(3y)70.46%
Cap/Depr(5y)95.47%
Cap/Sales(3y)2.65%
Cap/Sales(5y)5.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)816.22%
EPS 3Y90.7%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y100%
EPS Next 2Y101%
EPS Next 3Y71.68%
EPS Next 5YN/A
Revenue 1Y (TTM)15.11%
Revenue growth 3Y20.83%
Revenue growth 5Y71.51%
Sales Q2Q%36.51%
Revenue Next Year23.69%
Revenue Next 2Y20.05%
Revenue Next 3Y15.54%
Revenue Next 5Y10.33%
EBIT growth 1Y-65.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year307.59%
EBIT Next 3Y79.3%
EBIT Next 5Y46.66%
FCF growth 1Y-16.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.82%
OCF growth 3YN/A
OCF growth 5YN/A

DECIBEL CANNABIS CO INC / DB.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DECIBEL CANNABIS CO INC (DB.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to DB.CA.


What is the valuation status of DECIBEL CANNABIS CO INC (DB.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to DECIBEL CANNABIS CO INC (DB.CA). This can be considered as Fairly Valued.


How profitable is DECIBEL CANNABIS CO INC (DB.CA) stock?

DECIBEL CANNABIS CO INC (DB.CA) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for DB stock?

The Earnings per Share (EPS) of DECIBEL CANNABIS CO INC (DB.CA) is expected to grow by 100% in the next year.